Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort

Real‐world evidence on the course of Hepatitis C Virus (HCV) chronic liver disease after Sustained Virologic Response (SVR) obtained with direct‐acting antiviral drugs (DAAs) are still limited, and the effects on mortality remain unclear. We evaluated the post‐treatment survival of 4307 patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvaruso, Vincenza, Petta, Salvatore, Cacciola, Irene, Cabibbo, Giuseppe, Cartabellotta, Fabio, Distefano, Marco, Scifo, Gaetano, Di Rosolini, Maria Antonietta, Russello, Maurizio, Prestileo, Tullio, Madonia, Salvatore, Malizia, Giuseppe, Montineri, Arturo, Digiacomo, Antonio, Licata, Anna, Benanti, Francesco, Bertino, Gaetano, Enea, Marco, Battaglia, Salvatore, Squadrito, Giovanni, Raimondo, Giovanni, Cammà, Calogero, Craxì, Antonio, Di Marco, Vito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359835/
https://www.ncbi.nlm.nih.gov/pubmed/33896097
http://dx.doi.org/10.1111/jvh.13523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359835/
https://www.ncbi.nlm.nih.gov/pubmed/33896097
http://dx.doi.org/10.1111/jvh.13523

Ejemplares similares